Lv5
1045 积分 2022-03-31 加入
Tecotabart vedotin in Claudin 18.2-positive advanced gastric/gastroesophageal junction cancer: A Bayesian phase 1/2 clinical trial
11天前
已完结
The antibody–drug conjugate SHR-A1904 for targeting CLDN18.2 in advanced gastric or gastroesophageal junction cancer: a phase 1 trial
12天前
已完结
Application of unique chitosan nanoparticles as an anti-cariogenic bacterial agent in mouthwash: Physical, stability and antibacterial properties evaluation
1个月前
已完结
Lessons learned in linking PROTACs from discovery to the clinic
2个月前
已完结
β-catenin and its regulatory network
2个月前
已完结
Intrinsic/proximal cell surface marker logic-gated extracellular targeted protein degradation in specific cell population
2个月前
已完结
C-Arg9-APCR3-VHL promotes β-catenin degradation via the VHL-mediated ubiquitin–proteasome system in APC-mutant colorectal cancer
2个月前
已完结
Structure Defines Function: Clinically Relevant Mutations in ErbB Kinases
3个月前
已完结
Abstract 2114: Enhancing therapeutic strategies for osimertinib-resistant EGFR-mutant NSCLC: A HER3 dual-payload ADC (dpADC) with topoisomerase I and EGFR tyrosine kinase inhibitor
3个月前
已关闭
A novel human single-domain antibody-drug conjugate targeting CEACAM5 exhibits potent in vitro and in vivo antitumor activity
3个月前
已完结
皖公网安备34019202002308
